CLASS II Device recall · Reported 1 Apr 2015 · FDA Enforcement Report

RayStation Radiation Therapy Treatment Planning System recalled

Raysearch Laboratories AB is recalling RayStation Radiation Therapy Treatment Planning System, distributed nationwide in the US. The recall was initiated on 4 Mar 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesBuild numbers 3.5.0.16, 3.5.1.6, 4.0.0.14, 4.0.1.4, 4.0.2.9, 4.0.3.4, 4.5.0.19, 4.5.1.14 and 4.7.0.15
Quantity recalledDomestic: 245 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1310-2015
FDA event ID
70686
Recalling firm
Raysearch Laboratories AB, Stockholm
Classification
Class II
Status
Terminated
Recall initiated
4 Mar 2015
FDA classified
20 Mar 2015
Reported
1 Apr 2015
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Medical Software

Timeline

4 Mar 2015Recall initiated by company
20 Mar 2015Classified by FDA+16 days
1 Apr 2015Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

An issue with photon dose calculation for DMLC (Dynamic MLC) plans for machines where the MLC is positioned above the jaws, e.g. some Elekta linacs. The magnitude of the error depends on the beam model output factor corrections and on the individual DMLC plan characteristics.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

RayStation Radiation Therapy Treatment Planning System; -- RayStation 3.5, RayStation 4.0, RayStation 4.5 and RayStation 4.7. For RayStation 4.7, the issue applies also to machines with fixed jaws, regardless of MLC/jaw position. RayStation is a software system designed for treatment planning and analysis of radiation therapy.

Where it was distributed

Nationwide Distribution.

Nationwide

Questions about this recall

Why was it recalled?

An issue with photon dose calculation for DMLC (Dynamic MLC) plans for machines where the MLC is positioned above the jaws, e.g. some Elekta linacs. The magnitude of the error depends on the beam model output factor corrections and on the individual DMLC plan characteristics.

Which lots are affected?

Build numbers 3.5.0.16, 3.5.1.6, 4.0.0.14, 4.0.1.4, 4.0.2.9, 4.0.3.4, 4.5.0.19, 4.5.1.14 and 4.7.0.15

Where was it sold?

Nationwide Distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Raysearch Laboratories AB

All 115

Other Medical Software recalls

All 903